← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2002Last known activity
Jun 30, 2021
Timeline
1870s
- Jan 1, 1871
The Alfred Hospital— Founded
Drugs by trial phase (59 distinct, 48 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Alkalosis
- Aneurysm
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
- Arachnodactyly
- Bone Diseases, Metabolic
- Borderline Personality Disorder
- Bronchiectasis
- Cardiomyopathies
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Crohn Disease
- Cystic Fibrosis
- Delirium
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Disease
- Fibrosis
- Glioblastoma
- Heart Failure
- Infections
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Diseases
- Lung Diseases, Obstructive
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Major Depressive Disorder
- Marfan Syndrome
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myocardial Ischemia
- Neoplasms, Plasma Cell
- Osteoporosis
- Parkinson Disease
- Personality Disorders
- Postoperative Pain
- Preleukemia
- Psoriasis
- Psychomotor Agitation
- Psychotic Disorders
- Renal Insufficiency
- Respiratory Tract Infections
- Schizophrenia
- Syndrome
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT05357040Overall official - principal investigatorPhase 2Jun 30, 2021
- NCT04128891Overall official - principal investigatorPhase 3Feb 1, 2020
- NCT03541356Overall official - principal investigatorPhase 2May 8, 2018
- NCT02500446CollaboratorPhase 4Sep 28, 2015
- NCT02345590Overall official - principal investigatorPhase 4May 1, 2015
- NCT02097706Reponsible party - principal investigatorPhase 2Jan 1, 2015
- NCT02920541Overall official - principal investigatorPhase 1Jan 1, 2015
- NCT02189109CollaboratorPhase 1May 1, 2014
- NCT01937325Reponsible party - principal investigatorPhase 4Feb 1, 2014
- NCT01483053CollaboratorPhase 4Jan 1, 2014
- NCT01952470Overall official - principal investigatorPhase 2Oct 1, 2013
- NCT01952470Reponsible party - principal investigatorPhase 2Oct 1, 2013
- NCT01956006Reponsible party - principal investigatorPhase 1/Phase 2Oct 1, 2013
- NCT01849094Reponsible party - principal investigatorPhase 1/Phase 2May 1, 2013
- NCT01667094Reponsible party - principal investigatorPhase 4Sep 1, 2012
Details
- Founded
- Melbourne, US Jan 1, 1871
- Last known activity
- Jun 30, 2021